Retromer Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
2
Retromer Therapeutics General Information
Description
Developer of a new class of therapeutics designed to restore endolysosomal function in neurodegenerative diseases. The company offers innovative strategies to stabilize the retromer complex, enhance protein transport, and improve neuronal health, enabling patients with conditions like Alzheimer's and Parkinson's to potentially experience disease modification and improved quality of life.
Contact Information
Website
www.retromertherapeutics.comCorporate Office
- 300 East 33rd Street
- Apartment 14M
- New York, NY 10016
- United States
Corporate Office
- 300 East 33rd Street
- Apartment 14M
- New York, NY 10016
- United States
Retromer Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 01-Sep-2024 | Completed | Generating Revenue | |||
| 1. Corporate | 01-Jan-2020 | Completed | Generating Revenue |
Retromer Therapeutics Patents
Retromer Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024178386-A1 | Methods of treating endosomal trafficking diseases | Inactive | 24-Feb-2023 | ||
| WO-2024129696-A1 | Aav and lentiviral constructs comprising a sorl1 mini-gene for use in treating neurodegenerative diseases | Inactive | 12-Dec-2022 |
Retromer Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Crom Capital Management | Hedge Fund | Minority | ||
| CinRx Pharma | VC-Backed Company | Minority |
Retromer Therapeutics FAQs
-
When was Retromer Therapeutics founded?
Retromer Therapeutics was founded in 2020.
-
Where is Retromer Therapeutics headquartered?
Retromer Therapeutics is headquartered in New York, NY.
-
What industry is Retromer Therapeutics in?
Retromer Therapeutics’s primary industry is Drug Discovery.
-
Is Retromer Therapeutics a private or public company?
Retromer Therapeutics is a Private company.
-
What is Retromer Therapeutics’s current revenue?
The current revenue for Retromer Therapeutics is .
-
Who are Retromer Therapeutics’s investors?
Crom Capital Management and CinRx Pharma have invested in Retromer Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process